Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$37,394,632
+$8,613,190 QoQ
Shares Held
31,177
-0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#624
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. LLY ranks #1 (47.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,394,632 | 31,177 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $28,781,442 | 31,292 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $39,710,504 | 36,951 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $24,003,980 | 31,460 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $29,964,353 | 38,439 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $25,348,003 | 30,691 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $21,835,248 | 28,284 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $24,775,312 | 27,965 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $28,765,733 | 31,772 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $24,259,904 | 31,184 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,166,701 | 31,165 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $16,867,493 | 31,403 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $19,361,370 | 41,284 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $14,375,904 | 41,861 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $20,252,902 | 55,360 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $17,798,800 | 55,045 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $17,324,257 | 53,432 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $15,049,602 | 52,553 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $16,645,845 | 60,263 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $13,284,219 | 57,495 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $17,068,484 | 74,366 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $8,846,487 | 47,353 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $9,750,172 | 57,748 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $8,191,130 | 55,338 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $554,107 | 3,375 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $215,154 | 1,551 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||